Secoiridoids of olive and derivatives as potential coadjuvant drugs in cancer: A critical analysis of experimental studies
- PMID: 30772463
- DOI: 10.1016/j.phrs.2019.01.045
Secoiridoids of olive and derivatives as potential coadjuvant drugs in cancer: A critical analysis of experimental studies
Abstract
Phenolic secoiridoids from olive, including oleocanthal, oleuropein and related derivatives, are bioactive natural products with documented anticancer activities, that have mainly been attributed to their antioxidant, anti-inflammatory and antiproliferative effects. This review summarizes the results of the preclinical studies on the natural secoiridoids of olive used as single agents or in combination with other chemotherapeutics against cancer cells. The molecular targets of their action are described. A critical analysis of the importance of the experimental studies in view of the possible use in humans is also discussed.
Keywords: Adjuvant; Cancer; Hydroxytyrosol; Hydroxytyrosol (CID: 82755); Oleacein (CID: 18684078); Oleocanthal; Oleocanthal (CID: 11652416); Oleuropein; Oleuropein (CID: 5281544); Oleuropein aglycone (CID: 56842347); Olive secoiridoids; Tyrosol (CID: 10393).
Copyright © 2019 Elsevier Ltd. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources